SUBSCRIBE
SUBSCRIBE

Rezolute, Inc.

NEWS
BioForest
Clinical Catch-Up: May 31-June 5
As summer begins, we’re seeing a shift away from COVID-19-related news and a stronger output of other clinical trial news. Here’s a look.
June 5, 2020
 · 
10 min read
 · 
Mark Terry
BioForest
Clinical Catch-Up: May 25-29
In the lead-up to the ASCO Annual Meeting, companies were presenting some of their trial data, while other companies were presenting news related to COVID-19 studies. Here’s a look.
May 29, 2020
 · 
10 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
March 24, 2026
 · 
7 min read
Press Releases
Rezolute to Participate in the Citizens Life Sciences Conference
March 4, 2026
 · 
1 min read
Press Releases
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
February 12, 2026
 · 
7 min read
Press Releases
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
 · 
1 min read
Press Releases
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
January 7, 2026
 · 
8 min read
Press Releases
Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
December 11, 2025
 · 
6 min read
Press Releases
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 10, 2025
November 10, 2025
 · 
2 min read
Press Releases
Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
November 6, 2025
 · 
7 min read
Press Releases
Rezolute to Participate in Upcoming Investor Conferences - October 15, 2025
October 16, 2025
 · 
1 min read
Press Releases
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 9, 2025
October 9, 2025
 · 
2 min read
Load More